Home > Choose Your Impact > Oncology | Choose Your Impact

Choose Your Impact: Oncology

The cancer challenge—leading the way

The Sharett Institute of Oncology is a world leader in cancer research. Its staff is at the cutting edge of treatment of breast and ovarian cancer, melanoma, lung and pancreatic cancer and leukemia.

Because Ashkenazi Jews are ten times more likely to be carriers of BRCA breast cancer genes than the general population, Israel is an important research "laboratory." Hadassah Medical Organization was the first to implant BRCA-free embryos in a mother who carries the gene. Care and treatment at the extraordinary Marlene Greenebaum Multidisciplinary Breast Center are second to none.

HMO researchers have discovered that a special compound called BKT140 shrank lung cell tumors by about 50 percent in cell samples and laboratory mice. When BKT140 was combined with radiation therapy and chemotherapy, cancer cell growth decreased by about 90 percent in the lab. These are first steps in what may one day lead to a treatment or cure for lung cancer.

Related Stories

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America